Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$10000.0.

  • Tango Therapeutics' Tax Provisions fell 11851.85% to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $67000.0, marking a year-over-year decrease of 6528.5%. This contributed to the annual value of $208000.0 for FY2024, which is 5522.39% up from last year.
  • According to the latest figures from Q3 2025, Tango Therapeutics' Tax Provisions is -$10000.0, which was down 11851.85% from $35000.0 recorded in Q2 2025.
  • In the past 5 years, Tango Therapeutics' Tax Provisions ranged from a high of $185000.0 in Q4 2021 and a low of -$21000.0 during Q2 2021
  • For the 5-year period, Tango Therapeutics' Tax Provisions averaged around $48937.5, with its median value being $37500.0 (2024).
  • As far as peak fluctuations go, Tango Therapeutics' Tax Provisions surged by 323333.33% in 2023, and later tumbled by 11851.85% in 2025.
  • Quarter analysis of 5 years shows Tango Therapeutics' Tax Provisions stood at $185000.0 in 2021, then tumbled by 47.57% to $97000.0 in 2022, then crashed by 64.95% to $34000.0 in 2023, then plummeted by 76.47% to $8000.0 in 2024, then crashed by 225.0% to -$10000.0 in 2025.
  • Its Tax Provisions stands at -$10000.0 for Q3 2025, versus $35000.0 for Q2 2025 and $34000.0 for Q1 2025.